Prevalence and Incidence of Atrial Fibrillation in a Large Cohort of Adrenal Incidentalomas: A Long-Term Study.


Journal

The Journal of clinical endocrinology and metabolism
ISSN: 1945-7197
Titre abrégé: J Clin Endocrinol Metab
Pays: United States
ID NLM: 0375362

Informations de publication

Date de publication:
01 08 2020
Historique:
received: 31 03 2020
accepted: 08 05 2020
pubmed: 16 5 2020
medline: 9 2 2021
entrez: 16 5 2020
Statut: ppublish

Résumé

Chronic glucocorticoids excess leads to morphological and functional cardiac alterations, a substrate for arrhythmias. Autonomous cortisol secretion (ACS) in adrenal incidentalomas is a model of chronic endogenous hypercortisolism. To investigate prevalence and incidence of atrial fibrillation (AF) in a large cohort of patients with ACS. Retrospective study. University hospital. Patients evaluated between 1990 and 2018 for adrenal incidentalomas (n = 632), without pheochromocytoma, primary aldosteronism, Cushing syndrome, congenital adrenal hyperplasia, and adrenal malignancy. Cortisol after 1-mg dexamethasone suppression test < or > 50 nmol/L defined nonsecreting tumors (NST) (n = 420) and ACS (n = 212), respectively. Assessment of AF at baseline (n = 632) and during a median follow-up of 7.7 years retrospectively (NST, n = 249; ACS, n = 108). Comparison with general population. Prevalence and incidence of AF. AF prevalence was higher in patients with ACS (8.5%) than NST (3.1%, P = 0.003) and the general population (1.7%; P < 0.001 vs ACS, P = 0.034 vs NST). The age-adjusted rate ratio to the general population was 1.0 for NST and 2.6 for ACS. AF was associated with ACS (odds ratio, 2.40; 95% confidence interval [CI], 1.07-5.39; P = 0.035). The proportion of patients with AF at last evaluation was higher in ACS (20.0%) than NST (11.9%; P = 0.026). ACS showed a higher risk of incident AF than NST (hazard ratio, 2.95; 95% CI, 1.27-6.86; P = 0.012), which was associated with post-dexamethasone cortisol (hazard ratio, 1.15; 95% CI, 1.07-1.24; P < 0.001), independently of known contributing factors. Patients with adrenal incidentalomas and ACS are at risk of AF. Electrocardiogram monitoring may be recommended during follow-up.

Identifiants

pubmed: 32413902
pii: 5837818
doi: 10.1210/clinem/dgaa270
pii:
doi:

Substances chimiques

Hydrocortisone WI4X0X7BPJ

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

© Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Guido Di Dalmazi (G)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Valentina Vicennati (V)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Carmine Pizzi (C)

Division of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Cristina Mosconi (C)

Diagnostic and Interventional Radiology Unit, Department of Diagnostic and Preventive Medicine, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Lorenzo Tucci (L)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Caterina Balacchi (C)

Diagnostic and Interventional Radiology Unit, Department of Diagnostic and Preventive Medicine, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Eugenio Roberto Cosentino (ER)

Hypertension Unit, Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Pasquale Paolisso (P)

Division of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Flaminia Fanelli (F)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Alessandra Gambineri (A)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Carla Pelusi (C)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Andrea Repaci (A)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Silvia Garelli (S)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Nazzareno Galiè (N)

Division of Cardiology, Department of Experimental, Diagnostic and Specialty Medicine, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Claudio Borghi (C)

Hypertension Unit, Department of Medical and Surgical Sciences, S. Orsola-Malpighi Hospital, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Rita Golfieri (R)

Diagnostic and Interventional Radiology Unit, Department of Diagnostic and Preventive Medicine, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Uberto Pagotto (U)

Endocrinology and Diabetes Prevention and Care Unit, Department of Medical and Surgical Sciences, University Alma Mater Studiorum of Bologna, S. Orsola-Malpighi Hospital, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH